Medtronic to cut up to 900 jobs:
This article was originally published in Clinica
Medtronic said in a regulatory filing that it could lay off up to 900 employees, after the company was severely affected by a slowdown in the US implantable cardioverter defibrillator market. The Fridley, Minneapolis-based firm had previously announced that it was to cut 550 jobs (see Clinica No 1262, p 13) but has now upped this figure to include extra early retirements, voluntary departures and layoffs. As of July, 349 jobs had already been eliminated - the company incurred a $14m charge related to compensation expenses, which will be deducted from earnings for the first quarter of 2008.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.